The PCGP employs state-of-the-art genomic sequencing technologies to analyze the DNA and RNA of cancerous and normal cells from pediatric patients. Techniques such as whole-genome sequencing, exome sequencing, and transcriptome sequencing are utilized to identify genetic mutations, structural variations, and expression changes. Advanced bioinformatics tools are then used to analyze and interpret the vast amount of data generated, helping to identify potential driver mutations and therapeutic targets.
